Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS

Abstract

Abstract. Hepatocellular carcinoma (Hcc) is one of the most common types of cancer worldwide. The initial hepatocellular alterations that precede the appearence of Hcc include chronic viral hepatitis/cirrhosis, foci of phenotypically altered hepatocytes and, subsequently, dysplastic hepatocytes that form foci and nodules. These changes cause a discrepancy in the microenvironment of liver cells, which may result in changes in the protein expression profile of the cells. The aim of the present study was to investigate differences between the protein expression profiles at various stages of liver disease in order to better understand the mechanisms of Hcc and to identify potential biomarkers for its early diagnosis. The proteins of specific cells were obtained from Hcc tissue sections and pre-cancerous lesions using a manual microdissection technique, and were investigated by a two dimensional gel electrophoresis (2-de) Maldi-ToF MS proteomics approach. Select identified proteins were reconfirmed by immunohistochemistry. A total of 95 differentially expressed proteins, with an over 2-fold disparity in expression levels between cells of varying morphology during the stages of hepatocarcinogenesis, were detected by 2-de. among these 95 proteins, 80 were determined to be involved in numerous cell functions, including cell growth and proliferation, protein synthesis and metabolism, apoptosis and signal transduction. These identified proteins, which include stratifin (14-3-3), transgelin 2, heat-shock protein (HSP)70, HSP27, manganese superoxide dismutase, prohibitin, dJ1, α-enolase, peroxiredoxin 6, aldo-keto reductase family member B10, phosphoglycerate kinase 1, α-1-antitrypsin and nm23-H1, may play a role in the development of Hcc. Protein expression profiles differed markedly between the HCC tissue samples and pre-cancerous lesions, suggesting that alterations in protein expression occurred frequently during the process of hepatocarcinogenesis. analysis of the differential expression of proteins related to the development of Hcc may help elucidate the molecular mechanisms of the disease. These proteins may also serve as candidate biomarkers for early Hcc diagnosis. IntroductionHepatocellular carcinoma (Hcc) is one of the world's most common malignancies. The majority of Hcc cases are associated with chronic hepatitis or cirrhosis. Pathological changes in Hcc are involved in liver cell degeneration and necrosis, inflammatory cell infiltration, hepatocyte regeneration and fibrous tissue proliferation. During the development of Hcc, the liver undergoes a series of morphological changes, including chronic viral hepatitis/cirrhosis, foci of phenotypically altered hepatocytes and atypical hyperplasia (1-4). These changes result in an altered microenvironment, in which the intracellular protein expression pattern is changed as well.The proteomics approach allows for the analysis of changes in the protein expression profile of cells during disease progression. By comprehensively analyzing changes in protein expression patt...

Alpha-1 Antitrypsin: A Potent Anti-Inflammatory and Potential Novel Therapeutic Agent

“…This rich source of circulating AAT is primarily produced by hepatocytes within the liver (Rogers et al 1983); however, other cells, such as epithelial cells (Cichy et al 1997), monocytes , macrophages and neutrophils du Bois et al 1991), intestinal epithelial cells (Molmenti et al 1993), alpha and delta cells of human pancreatic islets (Bosco et al 2005) and cancer cells (Chen et al 2010) have also been shown to produce smaller quantities of the protein. The AAT molecule is synthesised as a single polypeptide chain that is post-translationally modified by glycosylation through the addition of N-glycosidically linked oligosaccharides (Kolarich et al 2006a, b) that exist as di-, tri-or tetra-antennary structures (Kolarich et al 2006b) (Fig.…”

Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model

“…While the mechanism responsible for its complex hepatocarcinogenesis is still under investigation, rapid hepatocellular carcinoma tumor proliferation due to dysregulation of the cell-cycle proteins is clear. Herein, we have taken advantage of the rapid proliferating nature of tumor cells in general and the high levels of hAAT expression found in hepatocellular carcinoma (30)(31)(32) and generated an effective vector system whereby transgene expression is dependent on the activation of two endogenously regulated promoters, i.e., 4ÂApoE/hAAT liver-specific promoter and recombinant human cyclin A2. In the context of oncolytic HSV-1, the 4ÂApoE/hAAT liver-specific promoter has also been shown to drive the expression of complementary sequences of selected miRNAs exclusively in hepatocellular carcinoma (33).…”

Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer

“…Conversely, down-regulation of miR-1 and miR-133a in human renal cell carcinoma resulted in up-regulation of the oncogenic TAGLN2 (30). Overexpression of TAGLN2 has been reported to serve as a potential biomarker for some cancer types, including colorectal cancer (31), hepatocellular carcinoma (32), and breast cancer (33,34). To our knowledge, the current study is the first study to report that urinary TAGLN2 can be used as a noninvasive biomarker for bladder cancer diagnosis and grade/stage discrimination.…”